|
 |
| home > news > detailed info |
|
|
 INDUSTRY NEWS AND PRESS RELEASES |
Azopharma Product Development Group, Inc |
|
|
Azopharma Announces the Addition of State of the Art Formulations Equipment
Phil Meeks, CEO of Azopharma comments, “The addition of these two
pieces of equipment compliment our comprehensive formulation
capabilities for all dosage forms and expands our ability to
manufacture tablets, capsules and powders.”
The MG Futura which comes equipped with a standard powder dosing unit
also has the ability to dose two different pellets into a single
capsule and is capable of production levels of 6,000/12,000/24,000 and
48,000 capsules per hour. Additionally, the MG Futura can perform
overencapsulation which is often used in blinded clinical studies. The
new Bausch & Strobel Aseptic Filling Isolator provides containment
and aseptic isolation during the powder filling operation while also
providing low humidity conditions. This piece of equipment will also be
a key component of Azopharma’s cytotoxic and potent compound production
activities.
Mr. Meeks adds, “Very few outsourcing providers have the scope and
depth of services provided by the Azopharma Product Development Group.
Azopharma serves as a true one-stop solution from post discovery
through clinical development. This investment in equipment and
facilities continues to solidify our position as the Total Product
Development CompanyTM servicing the pharmaceutical industry.”
Azopharma Product Development Group Includes:
• Azopharma Contract Pharmaceutical Services - Integrated product development and CTM manufacturing for all dosage forms.
• IQsynthesis - Synthetic chemistry services from discovery to clinical API supplies including large scale API synthesis.
• AniClin Preclinical Services - Preclinical services in support of early product development.
• ADMEquant Bioanalytical Services - Bioanalytical services supporting preclinical and clinical studies.
• Cyanta Analytical Laboratories - Analytical chemistry and inhalation services from development to quality control testing.
• ApiCross Drug Delivery Technologies - Proprietary drug delivery platforms to solve difficult molecular challenges.
• AvivoClin Clinical Services - Human clinical pharmacology services for Phase I/II/III clinical trials.
• Acromon Clinical Research Organization- Clinical monitoring, data management and statistical services.
About Azopharma
Azopharma Product Development Group is FDA registered, DEA approved and
client audited on a regular basis. Azopharma’s mission is to help our
customers turn Ideas Into Cures™. In product development, it comes down
to the right people, their commitment and application of experience.
Partnering with Azopharma provides customers with the confidence of
assured success. We welcome visits to our facility in Hollywood, FL as well as our other sites to conduct audits or meet
with our pharmaceutical scientists to outline a study that meets your
specific needs. Contact us at development@azopdogroup.com or call one
of our scientists at 954-433-7480.
Contact
Phil Meeks, CEO
Azopharma Product Development Group
2 Oakwood Boulevard, Suite 170
Hollywood, FL 33020
Phone: 954-433-7480
www.azopdogroup.com
|
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
Industry Events |
 |
7th Annual Pharma Packaging and Labelling conference
17 September - 18 October 2008, Barcelona
7th Annual Pharma Packaging and Labelling conference will bring
together experts from leading pharma manufacturers to present case study driven
presentations on critical industry-wide issues.
Attending this event will give you an opportunity to discuss with fellow
packaging and labelling professionals and share your views on these important
matters.
More info >> |
|
|
